<DOC>
	<DOCNO>NCT02720458</DOCNO>
	<brief_summary>Persistent insomnia high prevalence French general population affect 15.8 % 19 % adult . In France , disease mainly manage general practitioner ( GP ) usually propose intermediate half-life benzodiazepine Z-drugs first-line treatment . French Health authority recommend restrict consumption hypnotic 4 week , consider potential adverse effect ( memory impairment , alter sleep physiology , motor-vehicle crash ) , risk tolerance dependence . However , appear majority patient become chronic user . Therefore , discontinuation benzodiazepines/Z-drugs recommend , may appear challenge due withdrawal symptom psychological factor ( anticipatory anxiety , fear rebound insomnia ) . Numerous study show program base Cognitive-Behavioural Therapy ( CBT ) principles improve sleep daily life quality lead hypnotic taper maintain hypnotic abstinence insomniac patient . Cognitive-Behavioural Therapy ( CBT ) base 4 component : sleep restriction , stimulus control , cognitive therapy sleep hygiene education . This therapy dependent therapeutic alliance practitioner patient . Unfortunately , insufficient number train CBT expert especially France . The implementation internet-delivered self-help program base time-in-bed restriction stimulus control may issue within context general practice . Online program base CBT principle prove effective improve sleep daytime function population , study realize small patient group . Investigators hypothesis simple internet-delivered short-term program base sleep restriction therapy stimulus control ( follow GP consultation ) may facilitate hypnotic discontinuation ( benzodiazepines/Z-drugs ) patient insomnia disorder still report sleep complaint comparison taper alone ( access self-help program ) .</brief_summary>
	<brief_title>Self Help Program Hypnotics Withdrawal Insomniac Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypnotics Sedatives</mesh_term>
	<criteria>Patient complain persistent insomnia without comorbidities ( DSM5 ) treat least 3 month monotherapy : Zopiclone Zolpidem usual dos ( 4 dos per week least maximum 14 per week ) OR Intermediate halflife benzodiazepine include appendix 1 list usual dos ( 4 dos per week least maximum 14 per week ) Motivated stop hypnotic treatment ( score &gt; 5 1 10 degree VAS ) 18 75 year old , Man woman , Having internet connection , Affiliated national health service , Having give write informed consent participate trial . Patient 2 psychotropic drug take daily . Patient believe shortterm simple selfhelp program Insomnia comorbidities Night shiftworkers , Psychiatric disorder ( clinical interview ) : mood disorder ( depression , bipolar disorder ) BDI score &gt; 7 , anxiety disorder , psychosis All sleep disorder persistent insomnia ( clinical interview ) , Progressive neurological disease include restless legs syndrome , Cardiovascular disease treat hypertension ( clinical interview ) , Unstable respiratory endocrinological disease ( clinical interview ) , Drug addiction , alcohol addiction previous 6 month ( clinical interview ) , Having undertaken transmeridian travel ( Â± 3H ) previous 1 month Pregnant lactate woman , Current participation psychotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hypnotics withdrawal insomniac patient</keyword>
	<keyword>Cognitive-Behavioural Therapy ( CBT )</keyword>
	<keyword>Internet-delivered self-help program</keyword>
	<keyword>Sleep restriction</keyword>
	<keyword>Stimulus control</keyword>
	<keyword>Half-life benzodiazepine</keyword>
	<keyword>Z-drug</keyword>
</DOC>